Skip to main content
Clinical Trials/NL-OMON56762
NL-OMON56762
Not yet recruiting
Phase 3

AtRial fibrillation ablation to prevent disease progression of AF-induced atrial Cardiomyopathy in womEn and men - RACE X

niversitair Medisch Centrum Groningen0 sites604 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Atrial fibrillation
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
604
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- confirmed atrial cardiomyopathy (LAVI \>34 ml/m2\)
  • \- ECG\-confirmed atrial fibrillation
  • \- age: 65\-80 years old

Exclusion Criteria

  • \- permanent AF
  • \- previous AF ablation
  • \- heart failure NYHA III/IV
  • \- severe aortic or mitral valve disease
  • \- life expectancy \< 1 year

Outcomes

Primary Outcomes

Not specified

Similar Trials